Naltrexone Completed Phase 1 Trials for Analgesia Treatment

CompletedTreatment1 IdentifierTitleDrugs
NCT00398957An Open-Label Evaluation of the Dose Proportionality of OROS´┐Ż Hydromorphone HCL Tablets 8mg, 16mg, 32mg, 64mg
NCT00399295An Open-Label Evaluation of the Independent Effects of Coadministration of a High-Fat Meal and Naltrexone Blockade on the Pharmacokinetic Profile of Dilaudid OROS (Hydromorphone HCI) 16mg